Since our data suggest increased ES-GluN2B subunit levels with AD progression, we next wanted to investigate if increased ES-GluN2B subunit levels were due to altered PSA-NCAM expression across brain regions. This evidence concerns the gene NCAM1 and Alzheimer disease.